UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain

The New England journal of medicine, 2018-08, Vol.379 (8), p.722-730

2018

Volltextzugriff (PDF)

Treatment of Stage III Resectable Melanoma-Adjuvant and Neoadjuvant Approaches

The cancer journal (Sudbury, Mass.), 2024-03, Vol.30 (2), p.54-70

2024

Volltextzugriff (PDF)

Update on adjuvant therapy in late-stage resected melanoma

Clinical advances in hematology & oncology, 2021-12, Vol.19 (12), p.753

Tarhini, Ahmad A

2021

Volltextzugriff (PDF)

Safety and Efficacy of Combination Immunotherapy With Interferon Alfa-2b and Tremelimumab in Patients With Stage IV Melanoma

Journal of clinical oncology, 2012-01, Vol.30 (3), p.322-328

2012

Volltextzugriff (PDF)

Next Generation of Immunotherapy for Melanoma

Journal of clinical oncology, 2008-07, Vol.26 (20), p.3445-3455

2008

Volltextzugriff (PDF)

A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG‐ACRIN Cancer Research Group (E2607)

Cancer, 2017-07, Vol.123 (14), p.2688-2697

2017

Volltextzugriff (PDF)

A four-marker signature of TNF-RII, TGF-α, TIMP-1 and CRP is prognostic of worse survival in high-risk surgically resected melanoma

Journal of translational medicine, 2014-01, Vol.12 (1), p.19-19

2014

Volltextzugriff (PDF)

Aflibercept (VEGF Trap) in Inoperable Stage III or Stage IV Melanoma of Cutaneous or Uveal Origin

Clinical cancer research, 2011-10, Vol.17 (20), p.6574-6581

2011

Volltextzugriff (PDF)

Evaluation of Biodistribution of Sulforaphane after Administration of Oral Broccoli Sprout Extract in Melanoma Patients with Multiple Atypical Nevi

Cancer prevention research (Philadelphia, Pa.), 2018-07, Vol.11 (7), p.429-438

2018

Volltextzugriff (PDF)

Durability of response to immune checkpoint blockade following treatment discontinuation and efficacy of rechallenge in advanced Merkel cell carcinoma

Journal for immunotherapy of cancer, 2024-09, Vol.12 (9), p.e009816

2024

Volltextzugriff (PDF)

Neoadjuvant Pembrolizumab and High-Dose IFNα-2b in Resectable Regionally Advanced Melanoma

Clinical cancer research, 2021-08, Vol.27 (15), p.4195-4204

2021

Volltextzugriff (PDF)

Adjuvant immunotherapy of melanoma and development of new approaches using the neoadjuvant approach

Clinics in dermatology, 2013-05, Vol.31 (3), p.237-250

2013

Volltextzugriff (PDF)

A phase 2, randomized study of SB‐485232, rhIL‐18, in patients with previously untreated metastatic melanoma

Cancer, 2009-02, Vol.115 (4), p.859-868

2009

Volltextzugriff (PDF)

Melanoma Adjuvant Therapy

Hematology/oncology clinics of North America, 2014-06, Vol.28 (3), p.471-489

2014

Volltextzugriff (PDF)

Immune adverse events (irAEs) with adjuvant ipilimumab in melanoma, use of immunosuppressants and association with outcome: ECOG-ACRIN E1609 study analysis

Journal for immunotherapy of cancer, 2021-05, Vol.9 (5), p.e002535

2021

Volltextzugriff (PDF)

Biomarkers of therapeutic response in melanoma and renal cell carcinoma: potential inroads to improved immunotherapy

Journal of clinical oncology, 2009-06, Vol.27 (16), p.2583-2585

2009

Volltextzugriff (PDF)

Safety and efficacy of the antiganglioside GD3 antibody ecromeximab (KW2871) combined with high-dose interferon-α2b in patients with metastatic melanoma

Melanoma research, 2017-08, Vol.27 (4), p.342-350

2017

Volltextzugriff (PDF)

Improved prognosis and evidence of enhanced immunogenicity in tumor and circulation of high-risk melanoma patients with unknown primary

Journal for immunotherapy of cancer, 2022-01, Vol.10 (1), p.e004310

2022

Volltextzugriff (PDF)

Neoadjuvant therapy for high-risk bulky regional melanoma

Journal of surgical oncology, 2011-09, Vol.104 (4), p.386-390

2011

Volltextzugriff (PDF)

Cutaneous melanoma: available therapy for metastatic disease

Dermatologic therapy, 2006-01, Vol.19 (1), p.19-25

2006

Volltextzugriff (PDF)

Cutaneous melanoma: A model to study cancer metastasis

Journal of surgical oncology, 2011-05, Vol.103 (6), p.538-549

2011

Volltextzugriff (PDF)

Operable Melanoma: Screening, Prognostication, and Adjuvant and Neoadjuvant Therapy

American Society of Clinical Oncology educational book, 2017-05, Vol.37 (37), p.651-660

2017

Volltextzugriff (PDF)

The Tumor Microbiome as a Predictor of Outcomes in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibitors

Cancer research communications, 2024-08, Vol.4 (8), p.1978-1990

2024

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Aktive Filter

ThemaSkin Neoplasms - Pathology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(32)
Buchkapitel
(1)

Sprache

Englisch
(33)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain

Treatment of Stage III Resectable Melanoma-Adjuvant and Neoadjuvant Approaches

Update on adjuvant therapy in late-stage resected melanoma

Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)

Safety and Efficacy of Combination Immunotherapy With Interferon Alfa-2b and Tremelimumab in Patients With Stage IV Melanoma

Next Generation of Immunotherapy for Melanoma

A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG‐ACRIN Cancer Research Group (E2607)

A four-marker signature of TNF-RII, TGF-α, TIMP-1 and CRP is prognostic of worse survival in high-risk surgically resected melanoma

Aflibercept (VEGF Trap) in Inoperable Stage III or Stage IV Melanoma of Cutaneous or Uveal Origin

Evaluation of Biodistribution of Sulforaphane after Administration of Oral Broccoli Sprout Extract in Melanoma Patients with Multiple Atypical Nevi

Durability of response to immune checkpoint blockade following treatment discontinuation and efficacy of rechallenge in advanced Merkel cell carcinoma

Neoadjuvant Pembrolizumab and High-Dose IFNα-2b in Resectable Regionally Advanced Melanoma

Phase III Randomized Study of 4 Weeks of High-Dose Interferon-α-2b in Stage T2bNO, T3a-bNO, T4a-bNO, and T1-4N1a-2a (microscopic) Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E1697)

Adjuvant immunotherapy of melanoma and development of new approaches using the neoadjuvant approach

A phase 2, randomized study of SB‐485232, rhIL‐18, in patients with previously untreated metastatic melanoma

Melanoma Adjuvant Therapy

Immune adverse events (irAEs) with adjuvant ipilimumab in melanoma, use of immunosuppressants and association with outcome: ECOG-ACRIN E1609 study analysis

Biomarkers of therapeutic response in melanoma and renal cell carcinoma: potential inroads to improved immunotherapy

Safety and efficacy of the antiganglioside GD3 antibody ecromeximab (KW2871) combined with high-dose interferon-α2b in patients with metastatic melanoma

Improved prognosis and evidence of enhanced immunogenicity in tumor and circulation of high-risk melanoma patients with unknown primary

Neoadjuvant therapy for high-risk bulky regional melanoma

Cutaneous melanoma: available therapy for metastatic disease

Cutaneous melanoma: A model to study cancer metastasis

Operable Melanoma: Screening, Prognostication, and Adjuvant and Neoadjuvant Therapy

The Tumor Microbiome as a Predictor of Outcomes in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibitors

Aktive Filter

Suchergebnisse filtern